Needle Biopsy Market by Type (Core Needle Biopsy, Fine- Needle Aspiration Biopsy, Vacuum- Assisted Biopsy, Image- Guided Biopsy) by Utility (Disposable, Reusable) by Application (Tumor, Infection, Inflammation, Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Published Date: 22-Feb-2021 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-5852 Status : Published

Global Needle Biopsy Market accounted for USD 614.40 Million in 2019 and is expected to reach USD 892.40 Million by 2026, growing at a CAGR of 5.48%

Description

The needle biopsy market is set for a rapid growth over the forecast period. In terms of revenue, the global needle biopsy market accounted for USD 614.40 Million in 2019 and is expected to reach USD 892.40 Million by 2026, growing at a CAGR of 5.48%

Global Needle Biopsy Market: Overview

Needle biopsy is a medical diagnostic method used to obtain suspected tissue samples from the body for diagnosis/diagnosis of exclusion. Tissue samples accumulated from biopsy devices are sent to laboratory testing for analysis and diagnosis of various diseases. In order to categorize or assess the staging of diseases and rule out the existence of particular diseases, these tissue samples are analyzed.

Global Needle Biopsy Market

Global Needle Biopsy Market: Growth Factors

The needle biopsy market is mainly driven by the production of goods and the decline in the prices of raw materials and components. Rising cases of cancer and the increasing use of biopsy needles are fueling the market growth. Companies should concentrate on improving distribution quality in order to reduce price pressures due to massive market fragmentation. Distribution deals between major players and innovative goods, such as multi-layer needles, would be highly beneficial. The increase in the global geriatric population and government measures to spread cancer awareness are also expected to boost the market growth.

Needle biopsy provides non-invasive screening procedures to diagnose cancer by using liquids such as saliva, urine, blood, etc. to detect malignancy. Technological change may enhance the ability of needle biopsy and can substitute needle biopsy techniques. In needle biopsy, real-time progression of cancers is also feasible, raising the degree of danger to needle biopsy. It is expected that the dropping cost of goods due to greater fragmentation of the market and the rise of Chinese companies would bring additional pressure on prices. The growth of the needle biopsy market is challenged by increasing strict regulations and requirements for medical devices, and the uncertainty regarding reimbursement in the United States.

Global Needle Biopsy Market: Segmentation

The two fundamental forms of needle biopsies include fine aspiration needle biopsy and core needle biopsy. Core needle biopsy is a hollow needle measuring between 11 and 18 gauge and is used to extract a sample of tissue from the liver, breast, prostate and other organs. Local anesthesia is used to make the region numb until the tissue sample is collected. Fine needle aspiration typically needs a small hollow needle varying from 22–27-gauge needle to acquire just a small proportion of the damaged area. Fine needle biopsy is most widely used for the processing of thyroid samples.

Needle based biopsy guns is a lucrative strategy that many players are pursuing. Core needle biopsy has a greater efficiency and detectability than fine needle aspiration biopsy. The use of core needle biopsy to achieve the highest sensitivity and detectability in combination with needle aspiration biopsy is increasingly prevalent. As a consequence, the two tests are complementary and the efficiency rate is highest with both tests being performed together.

Vacuum-assisted needle biopsy is expected to be the fastest growing category. Rising rates of cancer screening in the world would stimulate the market. Among different types of cancer, breast cancer is expected to lead to the greatest use of needle biopsy.

Global Needle Biopsy Market: Regional Analysis

By Geography, the needle biopsy market is segmented into North America, Europe, Latin America, Asia Pacific, and Middle East and Africa.

North America dominated the global demand for needle biopsy in 2019, followed by Europe. In 2019, the United States held the largest market share for needle biopsy in the region, due to the involvement of key players, technical innovations, growing adoption of needle biopsy, increased spending on health care and appropriate reimbursement policies.

Europe is the second largest market due to high disposable incomes and increased awareness. Another market-driven factor in the region is the expanded implementation of national cancer screening programs and the rising acceptance of high-priced devices. In addition, increased coverage of refunds for biopsy processes and favorable demographics are other aspects of boosting market growth in the region.

The needle biopsy market in Asia Pacific is likely to expand at a highest CAGR during the forecast period. The growth of the market in the region can be attributed to the early adoption of advanced technologies such as core needle biopsy, fine-needle aspiration biopsy, etc., increased awareness, huge health expenditure, and high penetration of research activities across the region.

The Middle East & Africa market is dominated by gulf nations, especially the UAE, and Saudi Arabia. Poor regions of Africa are expected to be lagging behind due to poor economic and political stability and weak public healthcare system.

Global Needle Biopsy Market: Competitive Players

The major players in the global needle biopsy market include Boston Scientific Corporation, CareFusion Corporation, Cook Medical, Hologic, Inc, C. R. Bard, Inc, Medax, BD Hakko co. ltd, Moller Medical GmbH, and Argon Medical Devices, Inc. among others.

The report segment of global needle biopsy market are as follows:

Global Needle Biopsy Market: Type Segment Analysis

  • Core Needle Biopsy
  • Fine- Needle Aspiration Biopsy
  • Vacuum- Assisted Biopsy
  • Image- Guided Biopsy

Global Needle Biopsy Market: Utility Segment Analysis

  • Disposable
  • Reusable

Global Needle Biopsy Market: Application Segment Analysis

  • Tumor
  • Infection
  • Inflammation
  • Others

Global Needle Biopsy Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description
      • 1.1.1. Objective
      • 1.1.2. Target Audience
      • 1.1.3. Unique Selling Proposition (USP) & Offerings
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodulogy
      • 1.3.3. Level 1: Primary Research
      • 1.3.4. Level 2: Secondary Research
      • 1.3.5. Level 3: Data Validation and Expert Panel Assessment Report Description and Scope
  • Chapter 2. Executive Summary
    • 2.1. Global Needle Biopsy Market, 2016-2026, (USD Million)
    • 2.2. Needle Biopsy Market: Market snapshot
  • Chapter 3. Global Needle Biopsy Market – Industry Analysis
    • 3.1. Introduction
    • 3.2. Industry ecosystem analysis
    • 3.3. Technulogy landscape
    • 3.4. Market Drivers
      • 3.4.1. North America
      • 3.4.2. Europe
      • 3.4.3. Asia Pacific
      • 3.4.4. Latin America
      • 3.4.5. MEA
    • 3.5. Restraints
    • 3.6. Opportunity
    • 3.7. Innovation & sustainability
    • 3.8. Regulatory landscape
    • 3.9. Porter’s Five Forces Analysis
    • 3.10. PESTLE Analysis
    • 3.11. Needle Biopsy Market: Market Attractiveness Analysis
      • 3.11.1. Market Attractiveness Analysis by Type Segment
      • 3.11.2. Market Attractiveness Analysis by Utility Segment
      • 3.11.3. Market Attractiveness Analysis by Application Segment
  • Chapter 4. Global Needle Biopsy Market - Competitive Landscape
    • 4.1. Company Market Share Analysis, 2019
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions and Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Cullaborations and Joint Ventures
      • 4.2.4. Research & Development and Regional Expansion
  • Chapter 5. Needle Biopsy Market – Type Segment Analysis
    • 5.1. Global Needle Biopsy Market Revenue Share, by Type, 2019 & 2026 (USD Million)
    • 5.2. Global Needle Biopsy Market by Core Needle Biopsy, 2016 – 2026 (USD Million)
    • 5.3. Global Needle Biopsy Market by Fine- Needle Aspiration Biopsy, 2016 – 2026 (USD Million)
    • 5.4. Global Needle Biopsy Market by Vacuum- Assisted Biopsy, 2016 – 2026 (USD Million)
    • 5.5. Global Needle Biopsy Market by Image- Guided Biopsy, 2016 – 2026 (USD Million)
  • Chapter 6. Needle Biopsy Market – Utility Segment Analysis
    • 6.1. Global Needle Biopsy Market Revenue Share, by Utility, 2019 & 2026 (USD Million)
    • 6.2. Global Needle Biopsy Market by Disposable, 2016 – 2026 (USD Million)
    • 6.3. Global Needle Biopsy Market by Reusable, 2016 – 2026 (USD Million)
  • Chapter 7. Needle Biopsy Market – Application Segment Analysis
    • 7.1. Global Needle Biopsy Market Revenue Share, by Application, 2019 & 2026 (USD Million)
    • 7.2. Global Needle Biopsy Market by Tumor, 2016 – 2026 (USD Million)
    • 7.3. Global Needle Biopsy Market by Infection, 2016 – 2026 (USD Million)
    • 7.4. Global Needle Biopsy Market by Inflammation, 2016 – 2026 (USD Million)
    • 7.5. Global Needle Biopsy Market by Others, 2016 – 2026 (USD Million)
  • Chapter 8. Needle Biopsy Market - Regional Analysis
    • 8.1. Global Needle Biopsy Market: Regional Overview
      • 8.1.1. Global Needle Biopsy Market Revenue Share, By Region, 2019 & 2026 (USD Million)
    • 8.2. North America
      • 8.2.1. North America Needle Biopsy Market Revenue 2016 – 2026 (USD Million)
      • 8.2.2. North America Needle Biopsy Market Revenue, By Type, 2016 – 2026 (USD Million)
      • 8.2.3. North America Needle Biopsy Market Revenue, By Utility, 2016 – 2026 (USD Million)
      • 8.2.4. North America Needle Biopsy Market Revenue, By Application, 2016 – 2026 (USD Million)
      • 8.2.5. U.S.
        • 8.2.5.1. U.S. Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.2.5.2. U.S. Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.2.5.3. U.S. Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 8.2.6. Canada
        • 8.2.6.1. Canada Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.2.6.2. Canada Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.2.6.3. Canada Education & Learning Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 8.2.7. Mexico
        • 8.2.7.1. Mexico Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.2.7.2. Mexico Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.2.7.3. Mexico Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Needle Biopsy Market Revenue 2016 – 2026 (USD Million)
      • 8.3.2. Europe Needle Biopsy Market Revenue, By Type, 2016 – 2026 (USD Million)
      • 8.3.3. Europe Needle Biopsy Market Revenue, By Utility, 2016 – 2026 (USD Million)
      • 8.3.4. Europe Needle Biopsy Market Revenue, By Application, 2016 – 2026 (USD Million)
      • 8.3.5. UK
        • 8.3.5.1. UK Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.3.5.2. UK Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.3.5.3. UK Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.3.6.2. France Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.3.6.3. France Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 8.3.7. Germany
        • 8.3.7.1. Germany Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.3.7.2. Germany Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.3.7.3. Germany Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 8.3.8. Italy
        • 8.3.8.1. Italy Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.3.8.2. Italy Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.3.8.3. Italy Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 8.3.9. Spain
        • 8.3.9.1. Spain Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.3.9.2. Spain Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.3.9.3. Spain Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 8.3.10. Russia
        • 8.3.10.1. Russia Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.3.10.2. Russia Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.3.10.3. Russia Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 8.3.11. Rest of Europe
        • 8.3.11.1. Rest of Europe Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.3.11.2. Rest of Europe Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.3.11.3. Rest of Europe Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Needle Biopsy Market Revenue 2016 – 2026 (USD Million)
      • 8.4.2. Asia Pacific Needle Biopsy Market Revenue, By Type, 2016 – 2026 (USD Million)
      • 8.4.3. Asia Pacific Needle Biopsy Market Revenue, By Utility, 2016 – 2026 (USD Million)
      • 8.4.4. Asia Pacific Needle Biopsy Market Revenue, By Application, 2016 – 2026 (USD Million)
      • 8.4.5. China
        • 8.4.5.1. China Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.4.5.2. China Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.4.5.3. China Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.4.6.2. Japan Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.4.6.3. Japan Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 8.4.7. India
        • 8.4.7.1. India Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.4.7.2. India Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.4.7.3. India Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 8.4.8. Australia
        • 8.4.8.1. Australia Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.4.8.2. Australia Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.4.8.3. Australia Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 8.4.9. South Korea
        • 8.4.9.1. South Korea Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.4.9.2. South Korea Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.4.9.3. South Korea Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 8.4.10. Rest of Asia Pacific
        • 8.4.10.1. Rest of Asia Pacific Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.4.10.2. Rest of Asia Pacific Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.4.10.3. Rest of Asia Pacific Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Needle Biopsy Market Revenue 2016 – 2026 (USD Million)
      • 8.5.2. Latin America Needle Biopsy Market Revenue, By Type, 2016 – 2026 (USD Million)
      • 8.5.3. Latin America Needle Biopsy Market Revenue, By Utility, 2016 – 2026 (USD Million)
      • 8.5.4. Latin America Needle Biopsy Market Revenue, By Application, 2016 – 2026 (USD Million)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.5.5.2. Brazil Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.5.5.3. Brazil Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 8.5.6. Argentina
        • 8.5.6.1. Argentina Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.5.6.2. Argentina Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.5.6.3. Argentina Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 8.5.7. Rest of Latin America
        • 8.5.7.1. Rest of Latin America Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.5.7.2. Rest of Latin America Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.5.7.3. Rest of Latin America Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
    • 8.6. Middle East & Africa
      • 8.6.1. Middle East & Africa Needle Biopsy Market Revenue 2016 – 2026 (USD Million)
      • 8.6.2. Middle East & Africa Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
      • 8.6.3. Middle East & Africa Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
      • 8.6.4. Middle East & Africa Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 8.6.5. GCC Countries
        • 8.6.5.1. GCC Countries Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.6.5.2. GCC Countries Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.6.5.3. GCC Countries Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 8.6.6. South Africa
        • 8.6.6.1. South Africa Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.6.6.2. South Africa Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.6.6.3. South Africa Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 8.6.7. Rest of MEA
        • 8.6.7.1. Rest of MEA Needle Biopsy Market Revenue, by Type, 2016 – 2026 (USD Million)
        • 8.6.7.2. Rest of MEA Needle Biopsy Market Revenue, by Utility, 2016 – 2026 (USD Million)
        • 8.6.7.3. Rest of MEA Needle Biopsy Market Revenue, by Application, 2016 – 2026 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1. Boston Scientific Corporation
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product portfulio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. *Same information will be provided for below mentioned companies*
      • 9.2.1. CareFusion Corporation
      • 9.2.2. Cook Medical
      • 9.2.3. Hulogic, Inc
      • 9.2.4. C. R. Bard, Inc
      • 9.2.5. Medax
      • 9.2.6. BD Hakko co. ltd
      • 9.2.7. Muller Medical GmbH
      • 9.2.8. Argon Medical Devices, Inc.
      • 9.2.9. Others

Methodology


Frequently Asked Questions

The needle biopsy market is mainly driven by the production of goods and the decline in the prices of raw materials and components. Rising cases of cancer and the increasing use of biopsy needles are fueling the market growth. Companies should concentrate on improving distribution quality in order to reduce price pressures due to massive market fragmentation. Distribution deals between major players and innovative goods, such as multi-layer needles, would be highly beneficial. The increase in the global geriatric population and government measures to spread cancer awareness are also expected to boost the market growth.

Needle biopsy provides non-invasive screening procedures to diagnose cancer by using liquids such as saliva, urine, blood, etc. to detect malignancy. Technological change may enhance the ability of needle biopsy and can substitute needle biopsy techniques. In needle biopsy, real-time progression of cancers is also feasible, raising the degree of danger to needle biopsy. It is expected that the dropping cost of goods due to greater fragmentation of the market and the rise of Chinese companies would bring additional pressure on prices. The growth of the needle biopsy market is challenged by increasing strict regulations and requirements for medical devices, and the uncertainty regarding reimbursement in the United States.

According to Zion Market Research, the Needle Biopsy market is expected to generate revenue of around USD 892.40 Million by the end of 2026, growing at a CAGR of 5.48%.

By Geography, the needle biopsy market is segmented into North America, Europe, Latin America, Asia Pacific, and Middle East and Africa.

North America dominated the global demand for needle biopsy in 2019, followed by Europe. In 2019, the United States held the largest market share for needle biopsy in the region, due to the involvement of key players, technical innovations, growing adoption of needle biopsy, increased spending on health care and appropriate reimbursement policies.

Europe is the second largest market due to high disposable incomes and increased awareness. Another market-driven factor in the region is the expanded implementation of national cancer screening programs and the rising acceptance of high-priced devices. In addition, increased coverage of refunds for biopsy processes and favorable demographics are other aspects of boosting market growth in the region.

The needle biopsy market in Asia Pacific is likely to expand at a highest CAGR during the forecast period. The growth of the market in the region can be attributed to the early adoption of advanced technologies such as core needle biopsy, fine-needle aspiration biopsy, etc., increased awareness, huge health expenditure, and high penetration of research activities across the region.

The Middle East & Africa market is dominated by gulf nations, especially the UAE, and Saudi Arabia. Poor regions of Africa are expected to be lagging behind due to poor economic and political stability and weak public healthcare system.

The major players in the global needle biopsy market include Boston Scientific Corporation, CareFusion Corporation, Cook Medical, Hologic, Inc, C. R. Bard, Inc, Medax, BD Hakko co. ltd, Moller Medical GmbH, and Argon Medical Devices, Inc. among others.

 

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com